Log in

LON:INS - Instem Share Price, Forecast & News

GBX 467
+12.00 (+2.64 %)
(As of 02/17/2020 04:13 AM ET)
Today's Range
Now: GBX 467
50-Day Range
MA: GBX 442.71
52-Week Range
Now: GBX 467
Volume746 shs
Average Volume3,909 shs
Market Capitalization£77.63 million
P/E Ratio44.90
Dividend YieldN/A
Instem plc provides information technology solutions to the life science market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include Provantis, an integrated Windows-based system for organizations and universities that are engaged in non-clinical evaluation studies; submit platform that provides a suite of integrated tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; ALPHADAS, an eSource EDC system for early phase clinical trials; Animal Care Information System, an animal management software solution; Logbook, a repository for information; and Toxicology Resource Planning, a toxicology solution for pharmaceutical, chemical, and contract research laboratory corporations. Read More…

Industry, Sector and Symbol

Industry Healthcare Information Services
SectorComputer and Technology



Sales & Book Value

Annual Sales£23.90 million
Cash FlowGBX 38.64 per share
Book ValueGBX 104.80 per share



Market Cap£77.63 million
Next Earnings DateN/A
OptionableNot Optionable

Receive INS News and Ratings via Email

Sign-up to receive the latest news and ratings for INS and its competitors with MarketBeat's FREE daily newsletter.

Instem (LON:INS) Frequently Asked Questions

What is Instem's stock symbol?

Instem trades on the London Stock Exchange (LON) under the ticker symbol "INS."

Has Instem been receiving favorable news coverage?

News articles about INS stock have trended somewhat positive on Monday, InfoTrie reports. The research group identifies positive and negative news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Instem earned a coverage optimism score of 1.8 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Instem.

Who are some of Instem's key competitors?

What other stocks do shareholders of Instem own?

Who are Instem's key executives?

Instem's management team includes the folowing people:
  • Mr. Phil J. Reason, CEO & Exec. Director (Age 57)
  • Mr. Nigel John Goldsmith, CFO, Sec. & Exec. Director (Age 57)
  • Ms. Marybeth Thompson, Chief Operating Officer
  • Dr. Gordon Smith Baxter Ph.D., Chief Scientific Officer
  • Mr. Gary Mitchell, VP of Global Marketing

How do I buy shares of Instem?

Shares of INS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Instem's stock price today?

One share of INS stock can currently be purchased for approximately GBX 467.

How big of a company is Instem?

Instem has a market capitalization of £77.63 million and generates £23.90 million in revenue each year. Instem employs 217 workers across the globe.View Additional Information About Instem.

What is Instem's official website?

The official website for Instem is http://www.instem.com/.

How can I contact Instem?

Instem's mailing address is Diamond Way, Stone Business Park, STONE, ST15 0SD, United Kingdom. The company can be reached via phone at +44-1785-825600.

MarketBeat Community Rating for Instem (LON INS)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  92 (Vote Outperform)
Underperform Votes:  169 (Vote Underperform)
Total Votes:  261
MarketBeat's community ratings are surveys of what our community members think about Instem and other stocks. Vote "Outperform" if you believe INS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Featured Article: Pattern Day Trader

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel